Fresenius Kabi USA, LLC

Frequent Recalls

14

Recalls

0

Units Recalled

0

Injuries

0

Deaths

1 category · 2026-04-15 to 2026-04-15

Date	Source	Product	Brand	Severity	Units
2026-04-15	FDA Drug	FDA Recall: 0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 100 mL in a Single Dose freefle	Fresenius Kabi USA, LLC	Class II	N/A
2026-04-15	FDA Drug	FDA Recall: 0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL), 1,000 mL in a Single Dose freef	Fresenius Kabi USA, LLC	Class II	N/A
2026-04-15	FDA Drug	FDA Recall: 0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 250 mL in a Single Dose freefle	Fresenius Kabi USA, LLC	Class II	N/A
2026-04-15	FDA Drug	FDA Recall: 0.9% Sodium Chloride Injection, USP, 50 mL x60, Becton, Dickson and Company, 1 Beckton Drive, Frankl	Fresenius Kabi USA, LLC	Class II	N/A
2026-04-15	FDA Drug	FDA Recall: 0.9% Sodium Chloride Injection, USP 0.9% (450 mg per 50 mL) (9 mg per mL) 50 mL, Rx only, Fresenius	Fresenius Kabi USA, LLC	Class II	N/A
2026-04-15	FDA Drug	FDA Recall: 0.9% Sodium Chloride Injection, USP, 900 mg per 100 mL (9 mg per mL) 1,000 mL in a Single Dose freef	Fresenius Kabi USA, LLC	Class II	N/A
2026-04-15	FDA Drug	FDA Recall: 5% Dextrose Injection, USP 5 g per 100 mL (50 mg per mL) 100 mL in a 100 mL freeflex bag, Fresenius	Fresenius Kabi USA, LLC	Class II	N/A
2026-04-15	FDA Drug	FDA Recall: 5% Dextrose Injection, USP 12.5 g per 250 mL (50 mg per mL) 250 mL in a 250 mL freeflex bag, Freseni	Fresenius Kabi USA, LLC	Class II	N/A
2026-04-15	FDA Drug	FDA Recall: 5% Dextrose Injection, USP 2.5 g per 50 mL (50 mg per mL) 50 mL in a 100 mL freeflex bag, Fresenius	Fresenius Kabi USA, LLC	Class II	N/A
2026-04-15	FDA Drug	FDA Recall: 0.9% Sodium Chloride Injection, USP, (4,500 mg per 500 mL) (9 mg per mL) 500 mL in a 500 mL freeflex	Fresenius Kabi USA, LLC	Class II	N/A
2026-04-15	FDA Drug	FDA Recall: 0.9% Sodium Chloride Injection, USP, 0.9% (900 mg per 100 mL) (9 mg per mL) 100 mL in a 100 mL freef	Fresenius Kabi USA, LLC	Class II	N/A
2026-04-15	FDA Drug	FDA Recall: 0.9% Sodium Chloride Injection, USP 900 mg per 100 mL (9 mg per mL) 500 mL in a Single Dose freeflex	Fresenius Kabi USA, LLC	Class II	N/A
2026-04-15	FDA Drug	FDA Recall: 0.9% Sodium Chloride Injection, USP, (2,250 mg per 250 mL) (9 mg per mL) 250 mL in a 250 mL freeflex	Fresenius Kabi USA, LLC	Class II	N/A
2026-04-15	FDA Drug	FDA Recall: 0.45% Sodium Chloride Injection, USP, 1.125 grams per 250 mL (4.5 mg per mL), 250 mL in a 250 mL fre	Fresenius Kabi USA, LLC	Class II	N/A